Increased β-secretase activity and expression in rats following transient cerebral ischemia

Brain Research

Volumn 1009, Issue 1-2, 2004, Pages 1-8

  Wen, Yi ^a   Onyewuchi, Otuonye ^a   Yang, Shaohua ^a   Liu, Ran ^a   Simpkins, James W ^a  

^a UNIVERSITY OF NORTH TEXAS   (United States)

Author keywords

Alzheimer's disease; Amyloid precursor protein; BACE

Indexed keywords

ALPHA SECRETASE; BETA SECRETASE; BRAIN EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; NEOCORTEX; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSIENT ISCHEMIC ATTACK;

AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ENDOPEPTIDASES; BLOTTING, WESTERN; BRAIN; CELL DEATH; DENSITOMETRY; ENDOPEPTIDASES; FEMALE; FUNCTIONAL LATERALITY; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 2142815707     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2003.09.086     Document Type: Article

References (50)

1. Acquati F., Accarino M., Nucci C., Fumagalli P., Jovine L., Ottolenghi S., Taramelli R. The gene encoding DRAP (BACE2), a glycosylated transmembrane protein of the aspartic protease family, maps to the down critical region. FEBS Lett. 468:2000;59-64
2. Anderson A.J., Su J.H., Cotman C.W. DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J. Neurosci. 16:1996;1710-1719
3. Bederson J.B., Pitts L.H., Germano S.M., Nishimura M.C., Davis R.L., Bartkowski H.M. Evaluation of 2, 3, 5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 17:1986;1304-1308
4. Behl C. Apoptosis and Alzheimer's disease. J. Neural Transm. 107:2000;1325-1344
5. Benveniste H., Drejer J., Schousboe A., Diemer N.H. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369-1374
6. Bodendorf U., Danner S., Fischer F., Stefani M., Sturchler-Pierrat C., Wiederhold K.H., Staufenbiel M., Paganetti P. Expression of human beta-secretase in the mouse brain increases the steady-state level of beta-amyloid. J. Neurochem. 80:2002;799-806
7. Bremer A.M., Watanabe O., Bourke R.S. Artificial embolization of the middle cerebral artery in primates. Description of an experimental model with extracranial technique. Stroke. 6:1975;387-390
8. Citron M. Secretases as targets for the treatment of Alzheimer's disease. Mol. Med. Today. 6:2000;392-397
9. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A.Y., Seubert P., Vigo-Pelfrey C., Lieberburg I., Selkoe D.J. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature. 360:1992;672-674
10. Cotman C.W., Su J.H. Mechanisms of neuronal death in Alzheimer's disease. Brain Pathol. 6:1996;493-506
11. Farzan M., Schnitzler C.E., Vasilieva N., Leung D., Choe H. BACE2, a beta-secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein. Proc. Natl. Acad. Sci. U. S. A. 97:2000;9712-9717
12. Fukumoto H., Cheung B.S., Hyman B.T., Irizarry M.C. Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch. Neurol. 59:2002;1381-1389
13. Gasparini L., Netzer W.J., Greengard P., Xu H. Does insulin dysfunction play a role in Alzheimer's disease? Trends Pharmacol. Sci. 23:2002;288-293
14. Ginsberg M.D., Busto R. Rodent models of cerebral ischemia. Stroke. 20:1989;1627-1642
15. Gu Y., Misonou H., Sato T., Dohmae N., Takio K., Ihara Y. Distinct intramembrane cleavage of the beta-amyloid precursor protein family resembling gamma-secretase-like cleavage of Notch. J. Biol. Chem. 276:2001;35235-35238
16. Hardy J., Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci. 12:1991;383-388
17. Holsinger R.M., McLean C.A., Beyreuther K., Masters C.L., Evin G. Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease. Ann. Neurol. 51:2002;783-786
18. Hugon J., Esclaire F., Terro F., Yardin C. Apoptosis and Alzheimer disease. Contribution of cellular and transgenic models. Rev. Neurol. (Paris). 156:2000;123-125
19. Hussain I., Powell D., Howlett D.R., Tew D.G., Meek T.D., Chapman C., Gloger I.S., Murphy K.E., Southan C.D., Ryan D.M., Smith T.S., Simmons D.L., Walsh F.S., Dingwall C., Christie G. Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol. Cell. Neurosci. 14:1999;419-427
20. Iizuka T., Shoji M., Kawarabayashi T., Sato M., Kobayashi T., Tada N., Kasai K., Matsubara E., Watanabe M., Tomidokoro Y., Hirai S. Intracellular generation of amyloid beta-protein from amyloid beta-protein precursor fragment by direct cleavage with beta- and gamma-secretase. Biochem. Biophys. Res. Commun. 218:1996;238-242
21. Isacson O., Seo H., Lin L., Albeck D., Granholm A.C. Alzheimer's disease and down's syndrome: roles of APP, trophic factors and ACh. Trends Neurosci. 25:2002;79-84
22. Kratzsch T., Peters J., Frolich L. Etiology and pathogenesis of Alzheimer dementia. Wien Med. Wochenschr. 152:2002;72-76
23. LaFerla F.M. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat. Rev., Neurosci. 3:2002;862-872
24. Li Y., Chopp M., Powers C., Jiang N. Apoptosis and protein expression after focal cerebral ischemia in rat. Brain Res. 765:1997;301-312
25. Loeb C., Gandolfo C., Croce R., Conti M. Dementia associated with lacunar infarction. Stroke. 23:1992;1225-1229
26. Menzies S.A., Hoff J.T., Betz A.L. Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery. 31:1992;100-106. (discussion 106-7)
27. Milward E.A., Papadopoulos R., Fuller S.J., Moir R.D., Small D., Beyreuther K., Masters C.L. The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron. 9:1992;129-137
28. Murphy T., Yip A., Brayne C., Easton D., Evans J.G., Xuereb J., Cairns N., Esiri M.M., Rubinsztein D.C. The BACE gene: genomic structure and candidate gene study in late-onset Alzheimer's disease. NeuroReport. 12:2001;631-634
29. Nordstedt C., Lake S., Winblad B. Alzheimer's disease - an amyloid disease of the brain. Lakartidningen. 89:1992;4255-4260
30. Nunan J., Small D.H. Regulation of APP cleavage by alpha-, beta- and gamma-secretases. FEBS Lett. 483:2000;6-10
31. Onorato M., Mulvihill P., Connolly J., Galloway P., Whitehouse P., Perry G. Alteration of neuritic cytoarchitecture in Alzheimer disease. Prog. Clin. Biol. Res. 317:1989;781-789
32. Palmert M.R., Podlisny M.B., Golde T.E., Cohen M.L., Kovacs D.M., Tanzi R.E., Gusella J.F., Whitehouse P.J., Witker D.S., Oltersdorf T., et al. The beta amyloid protein precursor: mRNAs, membrane-associated forms, and soluble derivatives. Prog. Clin. Biol. Res. 317:1989;971-984
33. Paola D., Domenicotti C., Nitti M., Vitali A., Borghi R., Cottalasso D., Zaccheo D., Odetti P., Strocchi P., Marinari U.M., Tabaton M., Pronzato M.A. Oxidative stress induces increase in intracellular amyloid beta-protein production and selective activation of betaI and betaII PKCs in NT2 cells. Biochem. Biophys. Res. Commun. 268:2000;642-646
34. Rao A.V., Balachandran B. Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr. Neurosci. 5:2002;291-309
35. Rohn T.T., Rissman R.A., Head E., Cotman C.W. Caspase activation in the Alzheimer's disease brain: tortuous and torturous. Drug News Perspect. 15:2002;549-557
36. Rossner S., Apelt J., Schliebs R., Perez-Polo J.R., Bigl V. Neuronal and glial beta-secretase (BACE) protein expression in transgenic Tg2576 mice with amyloid plaque pathology. J. Neurosci. Res. 64:2001;437-446
37. Saitoh T., Sundsmo M., Roch J.M., Kimura N., Cole G., Schubert D., Oltersdorf T., Schenk D.B. Secreted form of amyloid beta protein precursor is involved in the growth regulation of fibroblasts. Cell. 58:1989;615-622
38. Simpkins J.W., Rajakumar G., Zhang Y.Q., Simpkins C.E., Greenwald D., Yu C.J., Bodor N., Day A.L. Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J. Neurosurg. 87:1997;724-730
39. Sinha S., Anderson J.P., Barbour R., Basi G.S., Caccavello R., Davis D., Doan M., Dovey H.F., Frigon N., Hong J., Jacobson-Croak K., Jewett N., Keim P., Knops J., Lieberburg I., Power M., Tan H., Tatsuno G., Tung J., Schenk D., Seubert P., Suomensaari S.M., Wang S., Walker D., John V., et al. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature. 402:1999;537-540
40. Sisodia S.S., St George-Hyslop P.H. Gamma-secretase, notch, abeta and Alzheimer's disease: where do the presenilins fit in? Nat. Rev., Neurosci. 3:2002;281-290
41. Slater A.F., Stefan C., Nobel I., van den Dobbelsteen D.J., Orrenius S. Signalling mechanisms and oxidative stress in apoptosis. Toxicol. Lett. 82-83:1995;149-153
42. Smith M.A., Richey Harris P.L., Sayre L.M., Beckman J.S., Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17:1997;2653-2657
43. Tamagno E., Bardini P., Obbili A., Vitali A., Borghi R., Zaccheo D., Pronzato M.A., Danni O., Smith M.A., Perry G., Tabaton M. Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol. Dis. 10:2002;279-288
44. Tatemichi T.K., Desmond D.W., Mayeux R., Paik M., Stern Y., Sano M., Remien R.H., Williams J.B., Mohr J.P., Hauser W.A., et al. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology. 42:1992;1185-1193
45. Tatemichi T.K., Paik M., Bagiella E., Desmond D.W., Stern Y., Sano M., Hauser W.A., Mayeux R. Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology. 44:1994;1885-1891
46. Vassar R. The beta-secretase, BACE: a prime drug target for Alzheimer's disease. J. Mol. Neurosci. 17:2001;157-170
47. Vassar R., Bennett B.D., Babu-Khan S., Kahn S., Mendiaz E.A., Denis P., Teplow D.B., Ross S., Amarante P., Loeloff R., Luo Y., Fisher S., Fuller J., Edenson S., Lile J., Jarosinski M.A., Biere A.L., Curran E., Burgess T., Louis J.C., Collins F., Treanor J., Rogers G., Citron M. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 286:1999;735-741
48. Yan R., Bienkowski M.J., Shuck M.E., Miao H., Tory M.C., Pauley A.M., Brashier J.R., Stratman N.C., Mathews W.R., Buhl A.E., Carter D.B., Tomasselli A.G., Parodi L.A., Heinrikson R.L., Gurney M.E. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature. 402:1999;533-537
49. Yan S.D., Zhu H., Zhu A., Golabek A., Du H., Roher A., Yu J., Soto C., Schmidt A.M., Stern D., Kindy M. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat. Med. 6:2000;643-651
50. Yankner B.A. New clues to Alzheimer's disease: unraveling the roles of amyloid and tau. Nat. Med. 2:1996;850-852